S&P 500   4,584.85 (+1.15%)
DOW   35,361.56 (+0.95%)
QQQ   372.42 (+1.62%)
AAPL   169.14 (+1.75%)
MSFT   310.80 (+2.46%)
FB   324.60 (+1.57%)
GOOGL   2,739.87 (+1.39%)
AMZN   3,133.83 (+0.25%)
TSLA   1,031.21 (+3.57%)
NVDA   253.08 (+0.96%)
BABA   133.73 (+4.69%)
NIO   30.37 (+6.08%)
AMD   127.30 (-0.76%)
CGC   7.97 (+4.32%)
MU   89.50 (-0.56%)
GE   101.25 (+0.63%)
T   27.36 (+0.29%)
F   22.35 (-0.45%)
DIS   151.82 (+1.14%)
AMC   19.16 (+4.59%)
PFE   54.05 (+0.95%)
ACB   5.00 (+2.88%)
BA   220.83 (+1.73%)
S&P 500   4,584.85 (+1.15%)
DOW   35,361.56 (+0.95%)
QQQ   372.42 (+1.62%)
AAPL   169.14 (+1.75%)
MSFT   310.80 (+2.46%)
FB   324.60 (+1.57%)
GOOGL   2,739.87 (+1.39%)
AMZN   3,133.83 (+0.25%)
TSLA   1,031.21 (+3.57%)
NVDA   253.08 (+0.96%)
BABA   133.73 (+4.69%)
NIO   30.37 (+6.08%)
AMD   127.30 (-0.76%)
CGC   7.97 (+4.32%)
MU   89.50 (-0.56%)
GE   101.25 (+0.63%)
T   27.36 (+0.29%)
F   22.35 (-0.45%)
DIS   151.82 (+1.14%)
AMC   19.16 (+4.59%)
PFE   54.05 (+0.95%)
ACB   5.00 (+2.88%)
BA   220.83 (+1.73%)
S&P 500   4,584.85 (+1.15%)
DOW   35,361.56 (+0.95%)
QQQ   372.42 (+1.62%)
AAPL   169.14 (+1.75%)
MSFT   310.80 (+2.46%)
FB   324.60 (+1.57%)
GOOGL   2,739.87 (+1.39%)
AMZN   3,133.83 (+0.25%)
TSLA   1,031.21 (+3.57%)
NVDA   253.08 (+0.96%)
BABA   133.73 (+4.69%)
NIO   30.37 (+6.08%)
AMD   127.30 (-0.76%)
CGC   7.97 (+4.32%)
MU   89.50 (-0.56%)
GE   101.25 (+0.63%)
T   27.36 (+0.29%)
F   22.35 (-0.45%)
DIS   151.82 (+1.14%)
AMC   19.16 (+4.59%)
PFE   54.05 (+0.95%)
ACB   5.00 (+2.88%)
BA   220.83 (+1.73%)
S&P 500   4,584.85 (+1.15%)
DOW   35,361.56 (+0.95%)
QQQ   372.42 (+1.62%)
AAPL   169.14 (+1.75%)
MSFT   310.80 (+2.46%)
FB   324.60 (+1.57%)
GOOGL   2,739.87 (+1.39%)
AMZN   3,133.83 (+0.25%)
TSLA   1,031.21 (+3.57%)
NVDA   253.08 (+0.96%)
BABA   133.73 (+4.69%)
NIO   30.37 (+6.08%)
AMD   127.30 (-0.76%)
CGC   7.97 (+4.32%)
MU   89.50 (-0.56%)
GE   101.25 (+0.63%)
T   27.36 (+0.29%)
F   22.35 (-0.45%)
DIS   151.82 (+1.14%)
AMC   19.16 (+4.59%)
PFE   54.05 (+0.95%)
ACB   5.00 (+2.88%)
BA   220.83 (+1.73%)
NASDAQ:SMED

Sharps Compliance Stock Forecast, Price & News

$6.41
+0.02 (+0.31%)
(As of 01/20/2022 11:59 AM ET)
Add
Compare
Today's Range
$6.32
$6.45
50-Day Range
$6.39
$8.47
52-Week Range
$6.37
$18.67
Volume
502 shs
Average Volume
83,668 shs
Market Capitalization
$123.26 million
P/E Ratio
8.90
Dividend Yield
N/A
Beta
-0.29
30 days | 90 days | 365 days | Advanced Chart
Receive SMED News and Ratings via Email

Sign-up to receive the latest news and ratings for Sharps Compliance and its competitors with MarketBeat's FREE daily newsletter.


Sharps Compliance logo

About Sharps Compliance

Sharps Compliance Corp. engages in the provision of healthcare waste management services including medical, pharmaceutical, and hazardous. It focuses on developing management solutions for medical waste and unused dispensed medications generated by small and medium quantity generators. The company was founded in November 1992 and is headquartered in Houston, TX.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Sanitary services
Sub-Industry
N/A
Current Symbol
NASDAQ:SMED
Employees
183
Year Founded
1994

Sales & Book Value

Annual Sales
$76.42 million
Cash Flow
$0.71 per share
Book Value
$2.71 per share

Profitability

Net Income
$12.87 million
Pretax Margin
17.73%

Debt

Price-To-Earnings

Miscellaneous

Free Float
18,306,000
Market Cap
$123.26 million
Optionable
Optionable

Company Calendar

Last Earnings
10/26/2021
Today
1/20/2022
Next Earnings (Confirmed)
1/26/2022
Fiscal Year End
6/30/2022

Social Links


MarketRank

Overall MarketRank

2.33 out of 5 stars

Industrial Products Sector

101st out of 248 stocks

Sanitary Services Industry

1st out of 8 stocks

Analyst Opinion: 3.3Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 3.1 5 -4 -3 -2 -1 -












Sharps Compliance (NASDAQ:SMED) Frequently Asked Questions

Is Sharps Compliance a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sharps Compliance in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Sharps Compliance stock.
View analyst ratings for Sharps Compliance
or view top-rated stocks.

How has Sharps Compliance's stock price been impacted by Coronavirus (COVID-19)?

Sharps Compliance's stock was trading at $5.38 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SMED shares have increased by 19.1% and is now trading at $6.41.
View which stocks have been most impacted by COVID-19
.

When is Sharps Compliance's next earnings date?

Sharps Compliance is scheduled to release its next quarterly earnings announcement on Wednesday, January 26th 2022.
View our earnings forecast for Sharps Compliance
.

How can I listen to Sharps Compliance's earnings call?

Sharps Compliance will be holding an earnings conference call on Wednesday, January 26th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 919-882-2331 with passcode "44124".

How were Sharps Compliance's earnings last quarter?

Sharps Compliance Corp. (NASDAQ:SMED) released its quarterly earnings results on Tuesday, October, 26th. The industrial products company reported ($0.04) EPS for the quarter, missing the Zacks' consensus estimate of ($0.03) by $0.01. The industrial products company earned $13.92 million during the quarter, compared to analysts' expectations of $13.49 million. Sharps Compliance had a net margin of 16.03% and a trailing twelve-month return on equity of 22.68%. During the same quarter in the previous year, the firm earned ($0.02) EPS.
View Sharps Compliance's earnings history
.

What price target have analysts set for SMED?

5 Wall Street analysts have issued 1 year price targets for Sharps Compliance's shares. Their forecasts range from $13.00 to $25.00. On average, they anticipate Sharps Compliance's stock price to reach $18.00 in the next year. This suggests a possible upside of 180.8% from the stock's current price.
View analysts' price targets for Sharps Compliance
or view top-rated stocks among Wall Street analysts.

Who are Sharps Compliance's key executives?

Sharps Compliance's management team includes the following people:

What is David P. Tusa's approval rating as Sharps Compliance's CEO?

41 employees have rated Sharps Compliance CEO David P. Tusa on Glassdoor.com. David P. Tusa has an approval rating of 85% among Sharps Compliance's employees.

What other stocks do shareholders of Sharps Compliance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sharps Compliance investors own include Alphabet (GOOG), Square (SQ), VBI Vaccines (VBIV), NVIDIA (NVDA), Alibaba Group (BABA), Walt Disney (DIS), Visa (V), AbbVie (ABBV), Avid Technology (AVID) and Gilead Sciences (GILD).

What is Sharps Compliance's stock symbol?

Sharps Compliance trades on the NASDAQ under the ticker symbol "SMED."

How do I buy shares of Sharps Compliance?

Shares of SMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sharps Compliance's stock price today?

One share of SMED stock can currently be purchased for approximately $6.41.

How much money does Sharps Compliance make?

Sharps Compliance has a market capitalization of $123.26 million and generates $76.42 million in revenue each year. The industrial products company earns $12.87 million in net income (profit) each year or $0.72 on an earnings per share basis.

How many employees does Sharps Compliance have?

Sharps Compliance employs 183 workers across the globe.

When was Sharps Compliance founded?

Sharps Compliance was founded in 1994.

What is Sharps Compliance's official website?

The official website for Sharps Compliance is www.sharpsinc.com.

Where are Sharps Compliance's headquarters?

Sharps Compliance is headquartered at 9220 KIRBY DRIVE STE 500, HOUSTON TX, 77054.

How can I contact Sharps Compliance?

Sharps Compliance's mailing address is 9220 KIRBY DRIVE STE 500, HOUSTON TX, 77054. The industrial products company can be reached via phone at (713) 432-0300, via email at [email protected], or via fax at 713-838-0508.


This page was last updated on 1/20/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.